We serve 2-(4-aminophenyl)acetonitrile CAS:3544-25-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Yellow crystal | Yellow crystal |
| Water | ≤ 0.5% | 0.25% |
| Assay | ≥ 99.0% | 99.61% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like 2-(4-aminophenyl)acetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzeneacetonitrile, 4-amino- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-aminophenyl-acetonitrile Use and application,4-aminophenylacetic acid nitrile technical grade,usp/ep/jp grade.
Related News: In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.3,3-diethyl-1,3,4,5-tetrahydro-benzo[c][1,2,5]thiadiazepine 2,2-dioxide manufacturer Amid mounting public skepticism over the effectiveness of Shuanghuanglian, the ruling Communist Party’s mouthpiece, the People’s Daily, warned Saturday morning that “inhibiting does not equal preventing and treating,” reminding the public not to rush to purchase the herbal remedy, or take it without medical supervision.1,5-diethyl-2-methyl-4,5-dihydro-1H-imidazole supplier Amid mounting public skepticism over the effectiveness of Shuanghuanglian, the ruling Communist Party’s mouthpiece, the People’s Daily, warned Saturday morning that “inhibiting does not equal preventing and treating,” reminding the public not to rush to purchase the herbal remedy, or take it without medical supervision.5-nitro-furan-2-sulfonic acid vendor Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.“Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.
